The c-foe serum response element (eRE) forms a ternary complex with the transcription factors SRF (serum response factor) and TCF (ternary complex factor). By itself, SRF can mediate transcriptional activation induced by serum, lysophosphatidic acid, or intracellular activation of heterotrimeric G proteins. Activated forms of the Rho family GTPases RhoA, Racl, and CDC42Hs also activate transcription via SRF and act synergistically at the SRE with signals that activate TCF. Functional Rho is required for signaling to SRF by several stimuli, but not by activated CDC42Hs or Racl. Activation of the SRF-linked signaling pathway does not correlate with activation of the MAP kinases ERK, SAPK/JNK, or MPK2/p38. Functional Rho is required for regulated activity of the c-foe promoter. These results establish SRF as a nuclear target of a novel Rho-mediated signaling pathway.
Introduction
The serum response element (SRE) is a regulatory sequence found in many growth factor-regulated promoters (reviewed by Treisman, 1990) . The SRE binds the ubiquitous transcription factor SRF (serum response factor; Norman et al., 1988) , which is required for its activity. At the c-fos SRE, SRF forms a ternary complex with TCF (ternary complex factor), which cannot bind the SRE by itself (Shaw et al., 1989) . In this complex, TCF, which comprises members of a small family of Ets domain proteins, including Elk-l, SAP-l, and SAP-2/ERP/NET, contacts an Ets recognition motif adjoining the SRF-binding site (for references see Treisman, 1994) . The TCFs regulate SRE activity in response to activation of the Ras-Raf-ERK pathway (see Treisman, 1994 ; also Kortenjann et al., 1994) , cooperating with the SRF C-terminal activation domain to activate transcription (Hill et al., 1993; Johansen and Prywes, 1993) .
Although c-fos promoter mutants that cannot bind TCF are not responsive to activation of the Ras-Raf-ERK pathway, they remain responsive to signals elicited by whole serum (Graham and Gilman, 1991) . TCF-independent serum-induced SRE activation is dependent on SRF, but does not require a growth factor-regulated phosphorylation of the protein at Ser-103 (Hill et al., 1994 ; Johansen *Present address: The Ludwig Institute for Cancer Research, 91 Riding House Street, London WlP 8BT, England. and Prywes, 1994) . Regulated transcriptional activation by SRF requires that it is bound to DNA via its own DNAbinding domain and is blocked by mutations in this domain that do not impair DNA binding: this suggests that SRF may change conformation upon binding DNA, allowing its interaction with a non-TCF "recognition factor" activated by serum-induced signals (Hill et al., 1994) . A similar model has been proposed for activation by MCM1, a Saccharomyces cerevisiae protein that is also involved in transcriptional regulation in response to extracellula~ signals and whose DNA-binding domain is 70% identical to that of SRF (Tan and Richmond, 1990; Bruhn and Sprague, 1994) .
The serum mitogen lysophosphatidic acid (LPA) can also activate c-fos promoter mutants that do not bind TCF, as can intracellular activation of heterotrimeric G proteins by aluminum fluoride ion (AIF4-; Hill and Treisman, submitted) . LPA, which acts via a heterotrimeric G protein-coupled putative serpentine receptor, activates multiple signaling pathways that lead to increased Ras-GTP formation and ERK activation, and also induce cytoskeletal rearrangements and tyrosine kinase activation (reviewed by Jalink et al., 1994; Moolenaar, 1995) . Two observations suggest that the latter responses are mediated by Rho, a member of the Ras superfamily of small GTPases (Hall, 1994) . First, microinjection of activated Rho has similar effects to LPA stimulation (Paterson et al., 1990; ; second, inactivation of endogenous Rho proteins by Clostridium botulinum C3 transferase blocks LPA-induced cytoskeletal rearrange-"ments and tyrosine phosphorylation Kumagai et al., 1993) . In this paper we have analyzed regulated transcription by SRF in more detail. We show that functional RhoA is required for LPA-, serum-, and AIF4--induced transcriptional activation by SRF and that tw~ other Rho family GTPases, Racl and CDC42Hs, can also potentiate SRF activity. These results establish SRF as the target of novel nuclear signaling pathways mediated by Rho family GTPases.
Results

The SRF-Binding Site Responds to Signaling Pathways Induced by Serum, LPA, and Heterotrimeric G Proteins
We have shown that c-foe promoter mutants that lack a TCF-binding site remain strongly responsive to serum, LPA, and AIF4- (Hill and Treisman, submitted) . To test whether SRF can mediate this response in the absence of other c-foe promoter elements, we examined regulation of the c-foe derivative 3D.AFOS. Here, thec-fos transcription unit is controlled by a minimal promoter consisting of three c-foe-derived SRF-binding sites inserted 5' to a Xenopus ,(-actin TATA box (Mohun et al., 1987) . This promoter does not contain an intact TCF-binding consensus sequence and is therefore defective in TCF binding (R. T. and J. W., unpublished data). The 3D.AFOS reporter or the wild-type human c-fos gene were transfected into mouse NIH 3T3 cells expressing the colony-stimulating factor 1 (CSF1) receptor ('1"56 cells; Roussel et al., 1990) , and c-fos RNA synthesis following various stimuli was monitored by RNase protection. Whole serum and LPA induced transcription of both genes; in contrast, tetradecanoyl phorbol acetate (TPA) and CSF1, which activate the c-fos promoter via TCFI failed to activate 3D.AFOS significantly (compare lanes 1-5 with 6-10 in Figure 1 ). The 3D.AFOS gene was also efficiently activated by AIF4-, produced in situ by the combination of aluminum chloride and sodium fluoride ( Figure   1 , lanes 11-15). We tested three other stimuli that require TCF to activate the c-fos promoter: epidermal growth factor (EG F), platelet-derived growth factor (PDGF), and ultraviolet C (UV-C) irradiation (Graham and Gilman, 1991; Sachsenmaier et al., 1994; Hill and Treisman, submitted) ; none of these efficiently activated the 3D.AFOS gene (Figure 1, . Similar results were obtained in NIH 3T3 cells (data not shown; see below). These data demonstrate that SRF-binding sites are sufficient to activate transcription in response to serum, LPA, and activation of heterotrimeric G proteins.
SRF
Mediates the Response to Serum, LPA, and AIF.-To provide direct evidence for the involvement of SRF in LPA-and AIF4--induced transcription, we used a previously described functional assay for serum-regulated activity of SRF (Hill et al., 1994) . This assay measures activity of SRE.LP, a mutant c-fos SRE comprising a low affinity SRF-binding site with no associated TCF-binding site. In transfected cells, endogenous SRF cannot saturate SRE.LP, which is therefore inactive; however, overexpression of wild-type SRF by a cotransfected expression plasmid is sufficient to restore serum inducibility of SRE.LP to -10% the level observed with the intact c-fos SRE (Hill et al., 1994) .
NIH 3T3 cells were transfected with an SRE.LPcontrolled reporter gene and stimulated with serum, LPA, or AIF4-. As a control, we used a reporter controlled by SRE.L, a derivative of the c-fos SRE that contains an intact high affinity-binding site for SRF, but lacks the TCFbinding site (Hill et al., 1994) . The SRE.L reporter was activated by LPA and AIF,-, although less efficiently than by whole serum (Figure 2, left) , while, as expected, the SRE.LP reporter responded to none of the stimuli (Figure  2 , right). Overexpression of wild-type SRF restored activity of SRE.LP to -10% the activityof SRE.L (Figure 2 , right). Two SRF DNA-binding domain mutants that cannot restore the serum-regulated activity of SRE.LP, SRF-M2 and 8 R F -1 9 8 / 2 0 3 (Hill et al., 1994) , also failed to restore the response of SRE.LP to LPA and AIF4- (Figure 2 , right). These data demonstrate that in addition to serum, LPA, and AIF4-can regulate transcriptional activation by SRF.
Activated Rho Family GTPases Potentiate TCF-Independent Transcription
We next investigated the roles of signaling molecules activated by the LPA receptor. At least some of the effects of LPA are mediated by Ras and Rho, small GTPases belonging to the Ras superfamily (reviewed by Hall, 1994; Jalink et al., 1994; Moolenaar, 1995) . We were particularly interested to test the involvement of Rho family proteins in regulation of SRF activity because these proteins may be involved in signaling to the nucleus in the heterotrimeric G protein-controlled yeast pheromone pathway (Schultz et al., 1995; see Discussion) . We therefore tested whether mutationally activated forms of Ha-Ras and the Rho family members RhoA, Racl, and CDC42Hs could activate the SRE independently of TCF. NIH 3T3 cells were transfected with CAT reporter genes controlled by either two copies of the wild-type c-los SRE, or its derivative SRE.L, which cannot bind TCF, together with expression plasmids producing the activated small GTPases Ras.R12, RhoA.V14, Rac1.V12, or CDC42Hs. V12. Coexpression of each of the proteins activated the wild-type SRE in the absence of growth factor stimulation, with an efficiency approaching that of serum stimulation in the case of CDC42Hs ( Figure 3A , left). In contrast, the SRE.L reporter responded only weakly to Ras.R12 but consistently exhibited a slightly enhanced response to the Rho family proteins (compare left and right panels in Figure 3A ; the low response of SRE.L to serum stimulation in this experiment was not reproducibly observed [Hill et al., 1994] ). Activation of SRE.L by Rho family proteins, serum, and LPA was abolished by an SRE mutation that prevents SRF binding (data not shown).
The data presented above suggest that activation of the SRE by Ras.R12 is mediated by TCF, but show that activated Rho family members can induce TCF-independent SRE activation. To test whether Rho family GTPases can also activate TCF, we tested their ability to potentiate transcriptional activation by NLex.EIkC, a LexA fusion protein containing the transcriptional activation domain of the TCF Elk-1 . LPA activates the ERKs via Ras (Jalink et al., 1994; Moolenaar, 1995) and can therefore potentiate transcriptional activation by NLex.EIkC (M. A. Price and R. T., unpublished data; Figure 3B ); however, although Ras. R12 strongly activated N Lex.EIkC, expression of the Rho family proteins did not increase activation above background levels, suggesting tha~they do not activate the ERKs ( Figure 3B ).
We next asked whether the response of the SRE to activated Rho family proteins is dependent on SRF, by testing the ability of SRF to potentiate the response of the SRE. LP reporter described above. For these experiments we concentrated on the RhoA.V14 and CDC42Hs.V12 proteins, Figure 2 ). Taken together, these data indicate that activated Rho family proteins can potentiate transcriptional activation by SRF.
TCF-and SRF-Linked Signaling Pathways Activate the SRE Synergistically
Three observations suggest that activation of the intact c-los SRE involves activation of both TCF-linked and SRFlinked signaling pathways. First, although mutations that block binding of TCF to the c-los SRE do not block induction by serum, binding of a transcriptionally incompetent TCF mutant can interfere with serum-induced transcription (Hill et al., 1994) . Second, endogenous TCF bound at the wild-type SRE consistently appears to have an inhibitory effect on transcriptional activation induced by activated Rho family proteins. Third, SRF DNA-binding domain mutations impair activity of the SRF-TCF ternary complex as well as TCF-independent activity (Hill et al., 1994) . To investigate these phenomena further, we exploited our ability to activate TCF-and SRF-linked signaling pathways independently. We previously constructed an altered specificity derivative of the TCF Elk-l, NL.EIk, that can form a ternary complex with SRF at SRE.L, which cannot bind endogenous TCF (Hill et al., 1993 (Hill et al., , 1994 . We used this protein to modulate the level of TCF present at SRE.L. As a control, we used NL.EIk307A, an NL.EIk derivative that lacks the C-terminal activation domain (Hill et al., 1993; . To activate TCF-and SRF-linked signaling pathways, we coexpressed either the activated Raf derivative, ANRaf (Howe et al., 1992) , or the activated Rho family proteins RhoA.V14 or CDC42Hs.V12. The data are shown in Figure 4A and summarized in Figure 4B .
As shown above, activity of SRE.L was strongly stimulated by coexpression of activated RhoA or CDC42Hs, but not by ANRaf, which also did not significantly potentiate activation by the Rho family proteins ( Figure 4A , gray bars). The NL.EIk protein potentiated the response of SRE.L to ANRaf, but inhibited its response to RhoA.V14 and CDC42Hs.V12; howeverTANRaf and either RhoA.V14 or CDC42Hs.V12 together synergistically activated SRE. L ( Figure 4A , closed bars). This phenomenon required the Elk-1 C-terminal activation domain: whereas cotransfection of NL.EIk307A also inhibited the response of SRE.L to RhoA.V14 or CDC42Hs.V12, it could not potentiate the response of SRE.L to ANRaf, even in the presence of activated Rho family proteins ( Figure 4A , open bars). Taken together, these results suggest a model in which TCF-and SRF-linked signaling pathways cooperate to activate the c-fos SRE ( Figure 4B ; see Discussion).
SRF and ERK Activation Can Be Dissociated
We next investigated whether activation of SRF-linked signaling pathways requires ERK activation. In Rat1 and COS-7 cells, LPA induces ERK activation via G~, which is sensitive to pertussis toxin (Jalink et al., 1994; Moolenaar, 1995) . We used an immune complex kinase assay to test whether ERK activation in NIH 3T3 cells expressing epitope-tagged ERK2 is also sensitive to pertussis toxin. Pretreatment with 100 ng/ml pertussis toxin reduced LPA- (right) . Data shown on the left are averaged from up to seven qualitatively similar independent experiments; standard deviations were on average 540/0 of the means shown here. Kinase activity in MEK-, SAPKa/~/~'-, and MPK2/ p38-specific immunoprecipitates was measured using GST.EIkC, GST. JunN, and GST.SAP2C substrates, respectively (right). Extracts were prepared 15 rain following induction, except for UV-C, which was after 1 hr (similar results were obtained when UV-C-induced SAPK/JNK activity was measured 10 or 30 min following stimulation). The numbers below the kinase assays are fold inductions over baseline and are the averages of two independent experiments. induced ERK2 activation to background levels and significant!y impaired serum-induced ERK2 activation ( Figure  5A , left panel, lanes 2, 3, 5, and 6); similar results were obtained using an ERK immunoblotting assay (data not shown). However, pertussis toxin treatment inhibited neither serum-or LPA-induced activation of SRE.L ( Figure  5A , right), nor accumulation of 3D.AFOS RNA (data not shown). Thus, serum-and LPA-induced activation of SRF does not appear to be mediated by G~ or to require ERK2 activation. Moreover, activated Rho family proteins did not potentiate ERK2 activity in the immune complex kinase assay ( Figure 5A, left panel, lanes 8-13) . These results suggest that ERK activation is neither necessary nor sufficient for activation of SRF.
SRF Activation Does Not Correlate with Activation of MEK, SAPK/JNK, or MPK2/p38 in NIH 3T3 cells
In addition to the ERKs, the related MAP kinases SAPK/ JNK and MPK2/p38 can be independently regulated by extracellular signals (reviewed by Cooper, 1994) . To assess whether activation of any of these enzymes correlates with induction of TCF-independent SRE activity, we tested the ability of agents reported to activate one or more of these pathways to activate SRE.L and analyzed kinase activity in parallel using immune complex kinase assays. In addition to the stimuli used so far, we also tested activation of the SRE.L reporter by osmotic shock and arsenite, which activate MPK2/p38 and SAPK/JNK. All the stimuli that activated SRE.L also activated MEK, the ERK2-activating enzyme; however, even though TPA strongly activated MEK, it did not activate SRE.L ( Figure 5B ). Similar results were obtained with PDGF, EGF, and CSF1 (data not shown; see Figure 1 ). Although UV-C irradiation strongly activated SAPK/JNK and MPK2/p38, it did not activate SRE.L ( Figure 5B ) or 3D.AFOS (see Figure 1) . Serum-and LPA-induced activation of SRE.L activity was also unaffected by treatment of cells with a pyridinyl imidazole M PK2/p38-specific inhibitor (data not shown). Taken together, these data strongly suggest that none of these MAP kinases is sufficient to mediate SRF-linked signaling pathways.
Effect of Inhibitors on SRF-Linked Signaling
We used specific inhibitors to test whether signaling molecules previously implicated in signaling by serum, LPA, and Rho family proteins are involved in SRF.linked signaling. Wortmannin (1 I~M) and rapamycin (0.4 p.g/ml), which, respectively, block LPA-induced phosphatidylinositide 3-kinase (PI3K) and serum-induced p70-$6 kinase activation in Swiss 3T3 cells, did not significantly affect regulation of SRE.L (data not shown). Thapsigargin pretreatment, which depletes endoplasmic Ca 2÷ and blocks LPA-or seru m-induced Ca 2+ mobilization, had little effect alone on SRE.L activity or 3D.AFOS RNA accumulation, but led to superinduction of the reporters when combined with LPA or serum induction (data not shown). This suggests that elevation of cytoplasmic Ca 2+ concentration is not a prerequisite for activation of the SRF-linked signaling pathway, but may potentiate its activity.
In Swiss 3T3 cells, LPA induces rapid Rho-dependent tyrosine phosphorylations associated with the formation of focal adhesions and p60 ~c kinase activation, which are inhibited upon disruption of the cytoskeleton by cytochalasin D (Jalink et al., 1994; Moolenaar, 1995; Ridley and Hall, 1994; Seufferlein and Rozengurt, 1994) . Our serumdeprived NIH 3T3 cells exhibited a high basal level of p125 FAK and paxillin tyrosine phosphorylation, which was not ii~Creased by LPA or serum stimulation. Tyrosine phosphorylation was abolished following a 40 min treatment with 2 I~M cytocholasin D, which itself strongly activated SRE.L, but had no effect on the ability of LPA or serum to induce c-fos transcription (data not shown). Finally, although the tyrosine kinase inhibitor tyrphostin 25 (50 p,M) led to an -2-fold reduction in SRE.L activity, the Srcdirected inhibitor herbimycin A (2 I~M) actually increased SRE.L activity 2-to 3-fold. Taken together, these results suggest that SRF-linked signaling requires neither tyrosine phosphorylation of focal adhesion-associated proteins nor the integrity of the actin cytoskeleton.
Rho Is Required for TCF-Independent SRE Activation by Extracellular Signals
The experiments described so far do not address whether RhoA, Racl, and CDC42Hs are intermediates on serum-, LPA-, or AIF4--induced signaling pathways to the SRE or whether they activate independent signaling pathways that converge at the SRE. C. botulinum C3 transferase specifically ADP-ribosylates Rho at Asn-41, thereby inactivating it (Paterson et al., 1990; Hall, 1994) . We therefore used intracellular C3 transferase expression to test whether functional Rho is required for the response to extracellular signals.
We first assessed the specificity of C3 transferase action by SDS-polyacrylamide gel electrophoresis (SDS-PAG E) (Paterson et al., 1990) . Expression of C3 led to decreased electrophoretic mobility of coexpressed epitope-tagged RhoA.V14, but not the Racl .V12 or CDC42Hs.V12 derivatives ( Figure 6A, lanes 1-8) ; modification of RhoA required Asn-41, since mutation of this residue prevented the C3-induced mobility shift ( Figure 6A , lanes 9-16). As a more rigorous test of C3 specificity, we tested its ability to inhibit Rho family-mediated activation of SRF-linked signaling pathways in vivo. Preliminary experiments demonstrated a slight sensitivity of the TK promoter used in our reporters to C3 expression, and so for these experiments, we used 3D.ACAT, a reporter gene analogous to 3D.AFOS (Mohun et al., 1987) . Activation of 3D.ACAT by RhoA.V14 was substantially inhibited by C3 coexpression, while activation by Racl .V12 and CDC42Hs.V12 was unaffected (Figure 6B) . As expected, activation of 3D.ACAT by the ADPribosylation-resistant RhoA derivative RhoA.V14/141 was also unaffected by C3 expression ( Figure 6B , lanes 9 and 10). Thus, C3 activity is Rho-specific in vivo, and activation of SRF-linked signaling pathways by activated Racl and CDC42Hs does not require functional Rho.
We next used C3 expression to test whether endogenous Rho is required for regulated activity of the 3D.ACAT reporter. As a control, we also tested the effect of C3 on activation of the TCF Elk.l, using the GAL4-derived fusion protein GaI.EIkC . Expression of C3 completely inhibited activation of 3D.ACAT, both by serum and other stimuli tested (Figu re 7A). In contrast, C3 expression had relatively little effect on activation of GaI.EIkC by serum, osmotic shock, and activated Ras, and it reduced activation by PDGF, TPA, and AIF4--2-fold (compare Figures 7A and 7B) . Surprisingly, C3 expression blocked activation of GaI.EIkC by arsenite and LpA, suggesting that in our NIH 3T3 cells, as in Swiss 3T3 cells, ERK2 activation by these stimuli is Rho dependent ( Figure 7B ; Kumagai et al., 1993) . We confirmed directly that LPA- and serum-induced ERK activation is indeed Rho dependent, by use of the immune complex kinase assay with extracts from cells expressing both epitope-tagged ERK2 and C3 transferase (see Figure 5A , lanes 2, 4, 5, and 7; data not shown). These data suggest that multiple extracellular signals activate an SRF-iinked signaling pathway that is dependent on a functional Rho protein. In contrast, activated forms of Racl or CDC42Hs signal to the SRE independently of Rho, suggesting that at least two SRF-linked signaling pathways therefore converge on the SRE (see Discussion).
RhoA Can Mediate Serum-, LPA-, and AIF4--Induced Signaling to SRF
It remained possible that the effects of C3 transferase upon signaling to the SRE observed in the preceding experiments were due to inactivation of substrates other than Rho. To confirm directly that a specific Rho family protein can mediate serum-, LPA-, and AIF4--induced signals, we exploited the fact that the RhoA.141 mutant is refractory to modification by C3 transferase (see Figure 6A ; Paterson et al., 1990 ). As shown above, C3 expression completely inhibited activation of the SRE-controlled reporter gene by serum, LPA, or AIF4-. However, coexpression of the ADP-ribosylation-resistant RhoA.141 protein effectively restored the response to serum and AIF4-and partially restored the LPA response (Figure 8) both the basal level of 3D.ACAT activity and the response to each stimulus (Figure 8 ). These results demonstrate that a specific Rho isotype, RhoA, can mediate signaling to the SRE by these stimuli.
Rho-and Ras-Dependent Signals Interact at the c-fos Promoter
Previous studies have shown that activation of the c-los promoter by many different stimuli can be inhibited by expression of the interfering Ras derivative Ras.N17. Although we have shown that a constitutively active Ras mutant does not efficiently activate the SRE independently of TCF, it remained possible that Ras.N17 might inhibit operation of the SRF-linked signaling pathway. To test this and to confirm that functional Rho activity is required for the rapid response of the SRE to extracellular stimuli, we used RNase protection to investigate the effect of Ras. N 17 or C3 transferase expression oQ induction of 3D.AFOS transcription. Serum-and LPA-induced transcription of the 3D.AFOS gene was effectively abolished by C3 coexpression, in agreement with the CAT assays, while the constitutive expression of the ~-globin reference gene was unaffected ( Figure 9, lanes 1-6) . However, activation of the 3D.AFOS reporter was also impaired by Ras.N17 ( Figure  9 , lanes 7-9; Ras.N17 reproducibly inhibits activity of the a-globin reference gene in NI H 3T3 cells). Thus, functional Ras also appears required for SRF-linked signaling, even though activated Ras is not sufficient for activation (see Discussion).
Finally, we used C3 transferase to test whether functional Rho is required for regulated c-los transcription. We examined induction by two kinds of stimulus: those that activate the c-los SRE via both SRF-and TCF-linked signaling pathways, such as serum and LPA, or those that activate only TCF-linked signaling pathways, such as TPA and polypeptide growth factors (see also Hill and Treisman, submitted) . Inactivation of endogenous Rho by C3 transferase expression dramatically reduced induction of the gene in response to all the stimuli (compare lanes 10- 1-9) or the intact c-los gene (pF711; lanes 10-19), together with the ~-globin reference plasmid MLVa118 and either EFC3 (5 I~g; lanes 4-6 and 15-19) or the Ras.N17 expression plasmid RSV.Ras.N17 (lanes 7-9) as indicated. Inductions were as described in Experimental Procedures. Total cell RNA, prepared from uninduced cells(lanes 1,4, 7, 10, and 15) or following a 30 rain treatment with FCS (15o, lanes 2, 5, and 8; 5O/o, lanes 11 and 16), LPA (lanes 3, 6, 9, 12, and 17), TPA (lanes 13 and 18), or PDGF (lanes 14 and 19) was~analyzed by RNase protection as described in the legend to Figure 1 . Note that Ras.N17 expression reproducibly reduces activity of the MLV-controlled reference gene in these experiments.
14 with lanes 15-19 in Figure 9 ). Functional Rho protein is therefore required for efficient activation of the c-fos promoter in response to multiple stimuli.
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Discussion
We have demonstrated that serum, LPA, and the heterotrimeric G protein activator AIF4-can activate the c-fos SRE. This activation requires SRF, but does not depend on formation of the ternary complex with TCF. Activation of SRF by serum-, LPA-, AIF4--, and stress-induced pathways requires a member of the Rho family of small GTPases and can be mediated by RhoA. Activated mutant forms of the other Rho family proteins Racl and CDC42Hs can also activate SRF independently of TCF, but do not require RhoA to do so, suggesting that at least two signaling pathways controlled by Rho family proteins target SRF. Activation of known MAP kinase pathways does not correlate with activation of SRF. Two kinds of signaling pathway converge at the SRE: one links TCF activity to the Rasinduced ERK activation, while the other links SRF activity to Rho family induced signals (see Figure 10A ). Several previousobservations have suggested that Rho family GTPases have roles in signaling to the nucleus and the control of cell proliferation (for discussion see Boguski and McCormick, 1993; Hall, 1994; Qiu et al., 1995) . Our data establish that Rho family proteins are involved in transmission of growth factor and mitogen signals to the nucleus and establish SRF as a target for such signals.
Signaling Pathways That Activate SRF
A variety of stimuli can activate transcription via SRF independently of TCF, including LPA, AIF4-, serum, osmotic shock, and arsenite treatment. LPA is presumed to act via a heterotrimeric G protein-coupled serpentine receptor (Jalink et al., 1994; Moolenaar, 1995) , and heterotrimeric G proteins are activated by AIF4-in the absence of ligand binding (Bigay et al., 1985) . Moreover, mutational analysis of c-fos promoter regulation shows that these agents can activate a signaling pathway distinct from those activated by receptor-tyrosine kinases (Hill and Treisman, submitted) . We propose that serum and LPA, which is abundant in serum, activate the same signaling pathway (see Figure  10) ; the comparatively stronger response of the SRE to whole serum may reflect the activity of other serum albumin-associated lipids (for discussion see Moolenaar, 1995) . It remains unclear at which point the serum-induced signal converges with those induced by osmotic shock and arsenite, as the sensors for these stress responses remain uncharacterized.
Three lines of evidence implicate RhoA in the SRFlinked signaling pathways discussed above. First, the activated form of RhoA can activate SRF in the absence of TCF. Second, expression of C. botulinum C3 transferase, which we demonstrated to inactivate Rho specifically, blocked activation of the SRE by these stimuli. Expression of C3 transferase in transfection experiments did not inhibit activation of other reporters, demonstrating that the observed effects are specific consequences of Rho inactivation. Third, when a C3-resistant RhoA derivative was coexpressed with C3 transferase, serum-, LPA-, and AIF4--induced signaling to SRF was restored, showing that RhoA is sufficient for signal transduction and that the C3 target is indeed Rho. This result also shows that C3 does not inhibit the responses to extracellular signals by affecting receptor activity or G protein activation. Our work also implicates the Rho family proteins Racl and CDC42Hs in signaling to SRF. However, it is not clear whether these proteins both activate the same pathway. They do not appear involved in LPA-and serum-induced SRE activation because expression of dominant negative versions of these molecules analogous to the Ras.N17 mutant , did not affect these responses (our unpublished data). Moreover, SRE activation by Rac1.V12 and CDC42Hs.V12 was not sensitive to C3 transferase. As will be discussed below, these proteins may therefore be involved in a parallel signaling pathway(s) to the SRE (Figure 10 ).
How Do Rho Family Proteins Signal °~to the Nucleus?
Recent studies have indicated that small GTPases can act in linked cascades (reviewed by Chant and Stowers, 1995) .Jn mammalian cells, studies of the roles of small GTPases in the assembly of actin-based structures suggest that CDC42Hs can activate Racl, which in turn can activate RhoA, while Ras activation can also lead to activation of Racl and RhoA Kozma et al., 1995; Nobes and Hall, 1995) . In contrast, two observations suggest that activation of SRFlinked signaling pathways does not involve cascades of this type. First, activation of SRF-linked signaling by CDC42Hs and Racl is not dependent on functional Rho; second, activated Ras does not activate SRF-linked signaling efficiently, even at levels that efficiently activate transcription by the TCF EIk-l. This apparent paradox might arise because the levels of activated small GTPases produced in our transfections, while sufficient to activate signaling pathways to the nucleus, are insufficient for activation of the next GTPase in the cascade. However, we cannot rule out the possibility that SRF activation by activated CDC42Hs and Racl may arise from promiscuous activation of nuclear signaling as a consequence of their overexpression. Identification of an extracellular stimulus that can activate SRF-linked signaling independently of Rho would help clarify this issue. For example, it is clear that both SRE activity and c-los expression can be potentiated following disruption of the cytoskeleton (Zambetti et al., 1991) , and it will be interesting to investigate the role of Rho family small GTPases in this process.
It is likely that serum-and LPA-induced tyrosine phosphorylation of focal adhesion-associated proteins such as paxillin and p125 FAK and cytoskeletal changes (Ridley and Hall, 1994; Seufferlein and Rozengurt, 1994) are not prerequisites for activation of SRF-linked signaling pathways.
In our NIH 3T3 cells, which are serum deprived rather than quiescent, tyrosine phosphorylation of p125 F^K and paxUlin is maximal and is not further increased by serum or LPA stimulation. Moreover, disruption of the cytoskeleton by cytochalasin D treatment, which reduces p125 FAK and paxillin tyrosine phosphorylation to background levels, itself strongly activates an SRF-linked signaling pathway and does not inhibit activation of c-los transcription by LPA or serum.
As yet we have been unable to correlate activation of a particular kinase with activation of the SRF-linked signaling pathway. ERK2 activation appears neither necessary nor sufficient: TPA activates ERK2 but not the SRF:linked pathway, and, conversely, pertussis toxin blocks LPAinduced ERK2 activation and impairs that by serum without affecting activation of SRF. Similiarly, activation of the SAPKs/JNKs and MPK2/p38 is strongly induced by UV irradiation but not sufficient to activate SRF-linked signaling pathways. Thus, although recent studies show that the SAPKs/JNKs can be activated by both G protein-coupled receptors (Coso et al., 1995a ) and a Racl-mediated signaling pathway (Coso et al., 1995b [this issue of Cell]; Minden et al., 1995 [this issue of Cell]), SAPKs/JNKs are not sufficient for activation of SRF. We also found that wortmannin and rapamycin, which inhibit LPA-induced PI3K activation and serum-induced p70-$6 kinase' activation, respectively, have no effect on LPA-or serum-induced SRF activation.
How, then, are Rho family-mediated signals transmitted to the SRE? An attractive idea, prompted by analogy with pheromone signaling in S. cerevisiae, is that the effector molecules for the proteins are related to the recently described p21-activated kinase (PAK) kinase family (Manser et al., 1994 ; see Figure 10 ). These serine/threonine kinases, of which the prototype appears to be the S. cerevisiae STE20 protein, are activated by interaction with GTP-bound CDC42Hs or Racl. As yet, no Rho-specific PAK-related cDNAs have been cloned, although a 70 kDa candidate protein has been identified (Manser et al., 1994) . According to this view, Rho-, CDC42Hs-, and Racl-mediated signaling pathways to SRF would converge at some point downstream of Rho, either via a common PAK-type kinase or via a common signaling molecule further downstream.
How Is SRF Activity Regulated?
We and others previously obtained data suggesting that serum-regulated SRF activity requires the intact DNAbound SRF DNA-binding domain (Hill et al., 1994; Johansen and Prywes, 1994) . Mutations in the SRF DNAbinding domain that do not block DNA binding impair both the ability of SRF to mediate TCF-independent transcriptional regulation and regulation in the context of the SRF-TCF ternary complex. We proposed that serum-induced signals target a recognition factor, distinct from TCF, that only interacts with the DNA-bound SRF DNAobinding domain (Hill et al., 1994) . Our data establish that the putative recognition factor is a potential substrate for Rho familymediated signals. We found that an SRE mutant, SRE.LP, which contains a low affinity SRF-binding site and which is consequently not responsive to serum stimulation, does retain significant activity in the presence of activated Rho family proteins, which can be further potentiated by overexpression of SRF. Perhaps the increased basal activity of SRE.LP in the presence of activated Rho family proteins reflects the continuous presence of active recognition factor, which might facilitate binding of SRF to the low affinity SRE.LP site. We are currently developing methods for the identification of the putative recognition factor.
Our data show that TCF-linked and SRF-Iin ked signaling pathways can cooperate to activate the c-fos SRE. When both TCF and SRF are simultaneously activated, by stimulation with activated Raf and Rho family proteins, respectively, SRE activation is much more efficient than with either stimulus alone. However, the presence of inactive TCF at the SRE interferes with Rho-induced activation. Thus, at SREs at which the ternary complex forms, efficient activation requires activation of both SRF-and TCFlinked signal pathways. This may explain the otherwise puzzling observation that although c-fos promoter mutants that cannot bind TCF remain serum inducible, their activity can be partially blocked by expression of a transcriptionally incompetent TCF mutant that can bind the SRE yet cannot be activated in response to signals (Hill et al., 1994) . It is therefore possible that agents that trigger only SRF-linked signaling pathways will induce only a subset of SRE-containing genes.
We also found that the basal activity of the SRE in serumdeprived cells is dependent on Rho; moreover, basal SRF activity could also be potentiated by overexpression of functional RhoA. If basal activity in SRF-linked signaling pathways is necessary for efficient function of the ternary complex, this might explain why c-fos activation, even by stimuli that do not efficiently stimulate the RhoA-linked signal pathway, is still sensitive to inactivation of Rho. Interestingly, SRF apparently acts constitutively to activate several muscle-specific promoters in concert with myogenic factors (Sartorelli et al., 1990) . We are currently testing the idea that background signal in the Rho pathway may be responsible for "constitutive" SRF activity, which is somehow potentiated by myogenic factors.
Interactions between Ras-and Rho-Dependent Signaling Pathways
Several observations suggest that Ras-and Rho-mediated signaling pathways may be mutually dependent, in the sense that although constitutive activation of Ras (or Rho) may not be sufficient to activate a particular signaling pathway, activity of that pathway can be blocked by expression of the dominant interfering Ras derivative Ras.N17 (or inactivation of Rho by C3 transferase). For example, activated Ras is not sufficient to activate SRF-lin ked signaling, yet expression of Ras.N17 inhibits activation of the SRFlinked pathway by extracellular stimuli that act through Rho. Similarly, although activated RhoA does not activate ERKs or TCF in our NIH 3T3 cells, inactivation of RhoA by C3 transferase blocks LPA-induced activation of ERK2, which is mediated by Ras. Finally, functional Rho is required for optimal activation of the c-fos gene in response to many different stimuli, including those that do not directly potentiate the activity of SRF-linked signaling pathways, such as PDGF and TPA.
We envisage two kinds of explanation for such crosstalk. First, it might reflect the activation by serum and LPA of a signaling molecule common to both pathways, such as a guanine nucleotide exchange factor (GEF): indeed, several GEFs with activity against both Ras and Rho family proteins have been described, and both Ras.N17 and ADP-ribosylated Rho proteins sequester GEFs (see Boguski and McCormick, 1993; Paterson et al., 1990) . According to this view, inhibitory effects of Ras.N17 could either be physiologically significant or arise as an artifact of GEF titration. Alternatively, cross-talk might arise because one pathway contains a component whose acti{,ity is indirectly dependent on basal activity in the other pathway, as is seen in the Rho dependence of PDGF-induced phospholipid breakdown, which arises because Rho is required for 4,5-PIP2 synthesis (Chong et al., 1994) . As mentioned above, if the activity of the SRF-TCF ternary complex is dependent on basal activity of SRF-linked signaling pathways, activation of c-fos by stimuli such as TPA or polypeptide growth factors, which activate TCF, would also be sensitive to inactivation of Rho. Clearly, more work needs to be done to resolve these issues.
Relationship to the S. cerevisiae Pheromone Pathway
There are intriguing potential parallels between the SRFlinked signaling pathway described here and the mating pheromone-induced pathway in S. cerevisiae (reviewed by Schultz et al., 1995; Figure 10) . Mating pheromone also binds to a serpentine receptor: signaling tothe nucleus is initiated by the 137 complex of the GPA1/STE4/STE18 heterotrimeric G protein, which indirectly leads to activation of the STE11-STE7-KSS1/FUS3 MAP kinase cascade. Two observations suggest that this pathwa.y may involve a Rho family protein. First, STE20, the kinase that controls activation of the MAP kinase cascade, is a homolog of the metazoan PAK kinases, which are regulated by Racl and CDC42Hs; apparently, STE20 can also bind CDC42Hs (Manser et al., 1994) . Second, loss-of-function mutations in a yeast Rho-GAP cause consititutive activation of the pheromone pathway, suggesting that a Rho family protein can activate the pathway (see Schultz et al., 1995) . Pheromone signals activate STE12, a transcription factor that activates transcription either autonomously or via transcription factor complexes with the SRF-related protein MCM1 (Ammerer, 1990; Yuan et al., 1993; Bruhn and Sprague, 1994) . STE12 is not obviously structurally related to TCF, and no metazoan counterparts have yet been reported. It is tempting to speculate that the SRFlinked signaling pathway found in mammalian cells may be more closely related to the evolutionarily ancient yeast pheromone pathway than has previously been thought.
Experimental Procedures Plasmids
All DNA manipulations were carried out by standard techniques, and the plasmid structures were verified by sequencing.
